These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34090951)

  • 21. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.
    Levin MJ
    J Clin Virol; 2014 Dec; 61(4):487-95. PubMed ID: 25453570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
    Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
    J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella virus-mononuclear cell interaction.
    White TM; Gilden DH
    Adv Virus Res; 2003; 62():1-17. PubMed ID: 14719363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster virus-induced transformation of mammalian cells in vitro.
    Gelb L; Dohner D
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):77s-81s. PubMed ID: 6330228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
    Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of matrix metalloproteinases in varicella zoster virus-infected human brain vascular adventitial fibroblasts.
    Nagel MA; Choe A; Rempel A; Wyborny A; Stenmark K; Gilden D
    J Neurol Sci; 2015 Nov; 358(1-2):444-6. PubMed ID: 26443282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory preparation of Varicella-Zoster Virus: concentration of virus-containing supernatant, use of a debris fraction and magnetofection for consistent cell-free VZV infections.
    Sloutskin A; Goldstein RS
    J Virol Methods; 2014 Sep; 206():128-32. PubMed ID: 24925132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line.
    Leventon-Kriss S; Gotlieb-Stematsky T; Vonsover A; Smetana Z
    Med Microbiol Immunol; 1979; 167(4):275-83. PubMed ID: 232537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic activity against varicella-zoster virus-infected target cells after marrow transplantation.
    Ljungman P; Bowden RA; Meyers JD
    J Clin Lab Immunol; 1990 Jan; 31(1):17-21. PubMed ID: 1966979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
    Arvin AM; Koropchak CM
    J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine.
    Somekh E; Levin MJ
    J Med Virol; 1993 Jul; 40(3):241-3. PubMed ID: 8394874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key issues in varicella-zoster virus latency.
    Kennedy PG
    J Neurovirol; 2002 Dec; 8 Suppl 2():80-4. PubMed ID: 12491156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between polymorphonuclear leukocytes and varicella-zoster virus-infected cells.
    Szanton E; Sarov I
    Intervirology; 1985; 24(2):119-24. PubMed ID: 2997077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Productive varicella-zoster virus infection of cultured intact human ganglia.
    Gowrishankar K; Slobedman B; Cunningham AL; Miranda-Saksena M; Boadle RA; Abendroth A
    J Virol; 2007 Jun; 81(12):6752-6. PubMed ID: 17409155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of varicella-zoster virus in lymphocytes by DNA hybridization.
    Vonsover A; Leventon-Kriss S; Langer A; Smetana Z; Zaizov R; Potaznick D; Cohen IJ; Gotlieb-Stematsky T
    J Med Virol; 1987 Jan; 21(1):57-66. PubMed ID: 3025357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.